Immunosuppressive properties of Wharton's jelly derived mesenchymal stromal cells in the treatment of graft versus host disease in rat model
Doctor of Philosophy === Department of Anatomy and Physiology === Mark L. Weiss === Graft Versus Host Disease (GVHD) is the major complication following hematopoietic stem cell transplantation. GVHD is activated by immunocompetent T cells presented in the donor grafted tissue. Due to the increased u...
Main Author: | Lopez Rodriguez, Yelica Virginia |
---|---|
Language: | en_US |
Published: |
Kansas State University
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/2097/16331 |
Similar Items
-
Wharton’s Jelly Mesenchymal Stem Cell: Various Protocols for Isolation and Differentiation of Hepatocyte-Like Cells; Narrative Review
by: Negar Varaa, et al.
Published: (2019-11-01) -
Wharton’s jelly absence: a possible cause of stillbirth
by: Eduarda Bittencourt Damasceno, et al.
Published: (2013-12-01) -
Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials
by: Katarzyna Stefańska, et al.
Published: (2020-04-01) -
In vitro effects of canine Wharton’s jelly mesenchymal stromal cells and nanoparticles on canine osteosarcoma D17 cell viability.
by: Reeds, Kimberly
Published: (2011) -
Germline cells derived from mesenchymal stem cells, with the focus on Wharton's jelly
by: Hossein Yazdekhasti, et al.
Published: (2018-01-01)